Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADORA3 | P0DMS8 | 5/20 | 1.00 |
| ▸ | ADORA2A | P29274 | 4/20 | 1.00 |
| ▸ | ADORA1 | P30542 | 4/20 | 1.00 |
| ▸ | ADORA2B | P29275 | 3/20 | 1.00 |
| ▸ | RAB9A | P51151 | 5/20 | 0.52 |
| ▸ | NPC1 | O15118 | 4/20 | 0.52 |
| ▸ | MEN1 | O00255 | 3/20 | 0.52 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.52 |
| ▸ | CASP3 | P42574 | 1/20 | 0.52 |
| ▸ | SENP8 | Q96LD8 | 1/20 | 0.52 |
| ▸ | SENP7 | Q9BQF6 | 1/20 | 0.52 |
| ▸ | SENP6 | Q9GZR1 | 1/20 | 0.52 |
| ▸ | POLB | P06746 | 2/20 | 0.50 |
| ▸ | CYP19A1 | P11511 | 1/20 | 0.47 |
| ▸ | SMN1; SMN2 | Q16637 | 5/20 | 0.46 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.46 |
| ▸ | HTT | P42858 | 2/20 | 0.45 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.45 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.44 |
| ▸ | NOTUM | Q6P988 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Trifluoroacetic Acid SCHEMBL4114413 | 0.85 | ADORA3 (0.72) | ADORA3ADORA2AADORA1ADORA2BRAB9A | |
| SCHEMBL3252621 | 0.81 | ADORA3 (0.68) | ADORA3ADORA2AADORA1ADORA2BRAB9A | |
| SCHEMBL9108544 | 0.79 | ADORA3 (0.66) | ADORA3ADORA2AADORA1ADORA2BRAB9A | |
| SCHEMBL11332250 | 0.79 | ADORA3 (0.66) | ADORA3ADORA2AADORA1ADORA2BMEN1 | |
| SCHEMBL20390138 | 0.79 | ADORA3 (0.66) | ADORA3ADORA2AADORA1ADORA2BRAB9A | |
| SCHEMBL20390644 | 0.79 | ADORA3 (0.66) | ADORA3ADORA2AADORA1ADORA2BRAB9A | |
| SCHEMBL9852272 | 0.79 | ADORA3 (0.66) | ADORA3ADORA2AADORA1ADORA2BRAB9A | |
| SCHEMBL16238754 | 0.79 | ADORA3 (0.66) | ADORA3ADORA2AADORA1ADORA2BRAB9A | |
| SCHEMBL30585815 | 0.79 | CYP19A1 (0.67) | ADORA3ADORA2AADORA1ADORA2BMEN1 | |
| SCHEMBL9230808 | 0.79 | CYP19A1 (0.67) | ADORA3ADORA2AADORA1ADORA2BMEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 325 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230072612-A1 | FLAME RETARDANT CHEMICAL COMPOSITIONS | NORDTREAT FINLAND OY (FI) | 2023-03-09 | — | — | US | claimed |
| EP-4097176-A1 | FLAME RETARDANT CHEMICAL COMPOSITIONS | Nordtreat Finland OY (FI) | 2022-12-07 | — | — | EP | claimed |
| CN-115087697-A | Flame retardant chemical composition | 诺德特利特芬兰公司 | 2022-09-20 | — | — | CN | claimed |
| US-11292968-B2 | Sulfenamides as flame retardants | SONGWON INTERNATIONAL AG (CH) | 2022-04-05 | — | — | US | claimed |
| CN-110872384-B | Flame retardant composition, use thereof and method for the production thereof | 松原国际股份有限公司 | 2022-02-25 | — | — | CN | claimed |
| WO-2021151493-A1 | FLAME RETARDANT CHEMICAL COMPOSITIONS | NORDTREAT FINLAND OY (FI) | 2021-08-05 | — | — | WO | claimed |
| EP-3066153-B1 | SULFENAMIDES AS FLAME RETARDANTS | SONGWON INT AG (CH) | 2020-05-06 | — | — | EP | claimed |
| CN-110872384-A | Flame retardant composition, use thereof and method for the production thereof | 松原国际股份有限公司 | 2020-03-10 | — | — | CN | claimed |
| CN-105829430-B | Sulfenamides as flame retardants | 松原国际股份有限公司 | 2019-11-15 | — | — | CN | claimed |
| US-20160289566-A1 | SULFENAMIDES AS FLAME RETARDANTS | SONGWON INTERNATIONAL AG (CH) | 2016-10-06 | — | — | US | claimed |
| EP-1937652-A1 | PYRIMIDINE AMIDE COMPOUNDS AS PGDS INHIBITORS | Aventis Pharmaceuticals Inc. (US) | 2008-07-02 | — | — | EP | claimed |
| WO-2007041634-A1 | PYRIMIDINE AMIDE COMPOUNDS AS PGDS INHIBITORS | AVENTIS PHARMACEUTICALS INC. (US) | 2007-04-12 | — | — | WO | claimed |
| EP-0272212-B1 | PROCESS FOR CONTINUALLY PRODUCING AZO OR HYDRAZONE DYES | CIBA-GEIGY AG (CH) | 1993-09-01 | — | — | EP | claimed |
| US-4925926-A | Preparation of cationic azo or hydrazone dyes in which the alkylation and the separation of the cationic dye are carried out continuously | CIBA-GEIGY CORPORATION (US) | 1990-05-15 | — | — | US | claimed |
| US-4810397-A | ALUMINUM COMPOUND, ACID, THIADIAZOLE OR TRIAZOLE | UNION OIL COMPANY OF CALIFORNIA (US) | 1989-03-07 | — | — | US | claimed |
| EP-0272212-A2 | Process for continually producing azo or hydrazone dyes | CIBA-GEIGY AG (CH) | 1988-06-22 | — | — | EP | claimed |
| US-4719001-A | ALUMINUM COMPOUND AND THIADIAZOLE DERIVATIVE | UNION OIL COMPANY OF CALIFORNIA (US) | 1988-01-12 | — | — | US | claimed |
| US-4288362-A | Monoazo pigments containing a quinazo linonylacetoacetanilide coupling component | BAYER AKTIENGESELLSCHAFT (DE) | 1981-09-08 | — | — | US | claimed |
| US-4217271-A | Basic azo dyestuffs containing a n-picolinium alkylene amino phenyl group | IMPERIAL CHEMICAL INDUSTRIES LIMITED (GB) | 1980-08-12 | — | — | US | claimed |
| US-4028323-A | WITH A SUBSTITUTED AMINOBENZENE | CIBA-GEIGY AG (CH) | 1977-06-07 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160289566-A1 | SULFENAMIDES AS FLAME RETARDANTS | STS, TST, PFAS | ADORA3 3578/4885ADORA2A 4029/4885ADORA1 4148/4885 |
| US-11292968-B2 | Sulfenamides as flame retardants | STS, TST, PFAS | ADORA3 3578/4885ADORA2A 4029/4885ADORA1 4148/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.